February 13, 2017 Galectin Presents Clinical Data of Combination Immunotherapy With Galectin-3 Inhibitor GR-MD-02 February 13, 2017 Galectin Therapeutics Inc. and the Providence Cancer Center recently announced the presentation of preclinical and early clinical data from two...